Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check5 days agoChange DetectedLocations section updated to include a full list of site states with revision v3.3.3. Individual per-state location blocks were removed.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded EU Trial (CTIS) Number 2024-514274-46-00 and updated location details to 104 sites, including Vinnytsia, Ukraine (21029), with primary completion date 2027-02-19. Removed note that the study had 103 locations and the old 'Last Update Posted' timestamp.SummaryDifference0.3%

- Check34 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a metadata update and does not alter study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe government funding notice about updates and processing status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedNo meaningful content changes detected; the study details and locations appear unchanged compared with the prior view.SummaryDifference0.2%

- Check84 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference3%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.